Expand NVAX Menu
NVAX MENU

NVAX Latest Press Releases

-- February 20, 2025 --

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 PRNewswire 8:00 AM

-- January 23, 2025 --

Brian Rosen, Commercial Strategy Senior Executive, Appointed as Director of Capstone Companies, Inc. Business Wire 9:00 AM

-- December 13, 2024 --

Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone PRNewswire 8:00 AM

-- December 4, 2024 --

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million PRNewswire 2:00 AM

-- November 18, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 9:12 PM

-- November 15, 2024 --

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) PRNewswire 7:48 AM

-- November 13, 2024 --

Novavax to Participate in Jefferies London Healthcare Conference PRNewswire 8:00 AM

-- November 12, 2024 --

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights PRNewswire 8:02 AM

-- November 11, 2024 --

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PRNewswire 8:30 AM

-- November 10, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 12:00 PM

-- November 4, 2024 --

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 PRNewswire 4:30 PM

-- November 2, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 12:00 PM

-- October 29, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Globe Newswire 4:00 PM

-- October 28, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Business Wire 4:00 PM

-- October 27, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm PRNewswire 4:00 PM

-- October 25, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 11:00 AM

-- October 23, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Globe Newswire 4:00 PM

-- October 20, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm Business Wire 4:00 PM

-- October 17, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 9:43 PM

-- October 16, 2024 --

Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PRNewswire 8:14 AM

-- October 9, 2024 --

Novavax's Updated 2024-2025 Nuvaxovid COVID-19 Vaccine Receives Authorization in the EU PRNewswire 7:00 AM

-- September 25, 2024 --

Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development PRNewswire 8:00 AM